Qihan Fu

机构：First Affiliated Hospital Zhejiang University · ORCID：0000-0003-2967-1812

发表论文 94 篇 · 总被引 2845 次 · h-index 26

代表论文

• RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial (2023 · EClinicalMedicine · 被引 74)
• Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC). (2024 · Journal of Clinical Oncology · 被引 53)
• Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial (2023 · Annals of Surgical Oncology · 被引 30)
• Phase I trial of hypoxia-responsive CEA CAR-T cell therapy in patients with heavily pretreated solid tumor via intraperitoneal or intravenous transfusion. (2024 · Journal of Clinical Oncology · 被引 26)
• Salivary Microbiome Relates to Neoadjuvant Immunotherapy Response in OSCC (2024 · Journal of Dental Research · 被引 21)
• Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8+ T cell activation in patients with advanced colorectal cancer (2025 · Molecular Therapy · 被引 18)